Clinical Trial Update: A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pharmacokinetics, safety and efficacy of darunavir/ritonavir (TMC114/ritonavir) in HIV-1 infected children and adolescents; the trial h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: HIV-1, HIV Infections | Phase 2 | Status: COMPLETED